Collectively, these findings are consistent with the levels of IgM being closely link with disease severity (27) and suggest distinct roles for the IgM and IgD isotypes in CLL, as only IgM associates with clinical markers. This evidence concerns the gene CD40LG and B-cell chronic lymphocytic leukemia.